Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy diversity 2-15 (IGHD2-15)
- Target
- IGHD2-15
- Molecular classification
- Immunoglobulin gene segment
01
Overview
Immunoglobulin heavy diversity 2-15 (IGHD2-15) is part of the immunoglobulin heavy chain (IGH) gene locus, specifically classified as a D (diversity) gene segment[2][4][5]. During early B-cell development, one D segment (such as IGHD2-15), one V (variable) segment, and one J (joining) segment undergo somatic recombination (V(D)J recombination) to generate the variable region of the immunoglobulin heavy chain[1][3]. This process creates the immense diversity of antibody recognition specificities needed for the adaptive immune response. IGHD2-15 is not a therapeutic target or a receptor/enzyme, but its sequence can influence the antibody repertoire generated in individuals. Genetic polymorphisms and variations within the IGH locus, including IGHD2-15, have been linked to differences in immune responsiveness and disease susceptibility in populations[3]. IGHD2-15 and related segments are mainly of research interest in immunology and genetics, not as clinical targets[2][4][5].
- Other names
- IGHD2-15IGHD215D2-15D2
02
Biological functions
Adaptive immune systemAntibody diversity generationV(D)J recombination
03
Disease associations
Influence on immune responsivenessInfluence on disease susceptibility
Beyond the preview
Go deeper on Immunoglobulin heavy diversity 2-15 (IGHD2-15).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunoglobulin heavy diversity 2-15 (IGHD2-15).